Cargando…

Editorial Commentary: Fifteen Years of Protection by Meningococcal C Conjugate Vaccines: Lessons From Disease Surveillance

Detalles Bibliográficos
Autores principales:	Maiden, Martin C. J., MacLennan, Jenny M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2014
Materias:	Articles and Commentaries
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4191561/ https://www.ncbi.nlm.nih.gov/pubmed/25069870 http://dx.doi.org/10.1093/cid/ciu599

Ejemplares similares

Editorial Commentary: The Endgame for Serogroup A Meningococcal Disease in Africa?
por: Maiden, Martin C. J.
Publicado: (2013)

Editorial Commentary: Out of Africa: Links Between Invasive Nontyphoidal Salmonella Disease, Typhoid Fever, and Malaria
por: MacLennan, Calman A.
Publicado: (2014)

Vaccine Impact and Effectiveness of Meningococcal Serogroup ACWY Conjugate Vaccine Implementation in the Netherlands: A Nationwide Surveillance Study
por: Ohm, Milou, et al.
Publicado: (2021)

Social Behavior and Meningococcal Carriage in British Teenagers
por: MacLennan, Jenny, et al.
Publicado: (2006)

Passive smoking, invasive meningococcal disease and preventive measures: a commentary
por: Rashid, Harunor, et al.
Publicado: (2012)

Vaccination strategies for the prevention of meningococcal disease
por: Vuocolo, Scott, et al.
Publicado: (2018)

Comparison of the Safety and Immunogenicity of a Novel Quadrivalent Meningococcal ACWY-Tetanus Toxoid Conjugate Vaccine and a Marketed Quadrivalent Meningococcal ACWY-Diphtheria Toxoid Conjugate Vaccine in Healthy Individuals 10–25 Years of Age
por: Halperin, Scott A., et al.
Publicado: (2014)

Characterization of vaccine antigens of meningococcal serogroup W isolates from Ghana and Burkina Faso from 2003 to 2009
por: Ispasanie, Emma, et al.
Publicado: (2014)

Surveillance of the impact of pneumococcal conjugate vaccines in developing countries
por: Rodgers, Gail L, et al.
Publicado: (2015)

Every Fifteen Days Forever?
por: Noris, Marina, et al.
Publicado: (2022)

Safety Monitoring in Group A Meningococcal Conjugate Vaccine Trials: Description, Challenges, and Lessons
por: Enwere, Godwin C., et al.
Publicado: (2015)

Editorial Commentary on the paper “Mandatory vaccination in Europe”
por: Hadjipanayis, Adamos, et al.
Publicado: (2020)

UKMenCar4: A cross-sectional survey of asymptomatic meningococcal carriage amongst UK adolescents at a period of low invasive meningococcal disease incidence
por: Bratcher, Holly B., et al.
Publicado: (2019)

Using the tetravalent meningococcal polysaccharide-protein conjugate vaccine in the prevention of meningococcal disease
por: Kimmel, Sanford R
Publicado: (2008)

Meningococcal conjugate vaccines: optimizing global impact
por: Terranella, Andrew, et al.
Publicado: (2011)

Factors contributing to the immunogenicity of meningococcal conjugate vaccines
por: Bröker, Michael, et al.
Publicado: (2016)

The Impact of Nucleotide Sequence Analysis on Meningococcal Vaccine Development and Assessment
por: Maiden, Martin Christopher James
Publicado: (2019)

Internal displacement in Colombia: Fifteen distinguishing features
por: Shultz, James M, et al.
Publicado: (2014)

Editorial Commentary
por: Mosli, Hisham A.
Publicado: (2011)

Exploiting Real-Time Genomic Surveillance Data To Assess 4CMenB Meningococcal Vaccine Performance in Scotland, 2015 to 2022
por: Rodrigues, C. M. C., et al.
Publicado: (2023)

Ethical Challenges and Lessons Learned During the Clinical Development of a Group A Meningococcal Conjugate Vaccine
por: Martellet, Lionel, et al.
Publicado: (2015)

Molecular epidemiology of meningococcal disease in England and Wales 1975–1995, before the introduction of serogroup C conjugate vaccines
por: Russell, Joanne E., et al.
Publicado: (2008)

B Part of It School Leaver protocol: an observational repeat cross-sectional study to assess the impact of a meningococcal serogroup B (4CMenB) vaccine programme on carriage of Neisseria meningitidis
por: Marshall, Helen S, et al.
Publicado: (2019)

Development strategy and lessons learned for a 10-valent pneumococcal conjugate vaccine (PNEUMOSIL®)
por: Alderson, Mark R., et al.
Publicado: (2021)

Immunogenicity and safety of a quadrivalent meningococcal tetanus toxoid-conjugate vaccine (MenACYW-TT) vs. a licensed quadrivalent meningococcal tetanus toxoid-conjugate vaccine in meningococcal vaccine-naïve and meningococcal C conjugate vaccine-primed toddlers: a phase III randomised study
por: van der Vliet, D., et al.
Publicado: (2021)

Surveillance of adverse events following immunization with meningococcal group C conjugate vaccine: Tuscany, 2005-2012
por: LEVI, M., et al.
Publicado: (2014)

Conjugate Meningococcal Vaccines Development: GSK Biologicals Experience
por: Miller, Jacqueline M., et al.
Publicado: (2011)

Technical Development of a New Meningococcal Conjugate Vaccine
por: Frasch, Carl E., et al.
Publicado: (2015)

Commentary: Lessons from the National Lung Screening Trial
por: Raymond, Daniel P.
Publicado: (2021)

Meningococcal serogroups A, C, W-135, and Y tetanus toxoid conjugate vaccine: a new conjugate vaccine against invasive meningococcal disease
por: Hedari, Carine P, et al.
Publicado: (2014)

The Diversity of Meningococcal Carriage Across the African Meningitis Belt and the Impact of Vaccination With a Group A Meningococcal Conjugate Vaccine
Publicado: (2015)

Meningococcal Carriage among Adolescents after Mass Meningococcal C Conjugate Vaccination Campaigns in Salvador, Brazil
por: Nunes, Amélia Maria Pithon Borges, et al.
Publicado: (2016)

Meningococcal disease before and after the introduction of meningococcal serogroup C conjugate vaccine. Federal District, Brazil
por: Tauil, Márcia de Cantuária, et al.
Publicado: (2014)

Meningococcal ACWYX conjugate vaccine in 2–29 year-olds in Mali and Gambia
por: Haidara, Fadima Cheick, et al.
Publicado: (2023)

Effect of a serogroup A meningococcal conjugate vaccine (PsA–TT) on serogroup A meningococcal meningitis and carriage in Chad: a community study
por: Daugla, DM, et al.
Publicado: (2013)

A Mouse Immunogenicity Model for the Evaluation of Meningococcal Conjugate Vaccines
por: Arunachalam, Arun B., et al.
Publicado: (2022)

Improvements in the outcome of children with meningococcal disease
por: Paize, Fauzia, et al.
Publicado: (2007)

Editorial Commentary: Paraneoplastic Syndromes
por: Katrak, Sarosh M
Publicado: (2021)

Gonococcal Vaccine Development: Lessons from Group B Meningococcal Vaccines
Publicado: (2017)

JITC launches a new section: commentary and editorials
por: Capitini, Christian M., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_fp08t0hrpq4r6oig27vpesa5v7